Seroatlas · Human Serome Atlas

FXYD1

Phospholemman

Also known as: PLM, PLM_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
O00168
Gene
FXYD1
Ensembl
ENSG00000266964
Chromosome
19
Canonical length
92 aa
Protein class
Predicted membrane proteins, Transporters
Subcellular location
Nucleoplasm,Nucleoli,Cytosol
Quaternary structure
Homotetramer

OverviewNCBI Gene

This gene encodes a member of a family of small membrane proteins that share a 35-amino acid signature sequence domain, beginning with the sequence PFXYD and containing 7 invariant and 6 highly conserved amino acids. The approved human gene nomenclature for the family is FXYD-domain containing ion transport regulator. Mouse FXYD5 has been termed RIC (Related to Ion Channel). FXYD2, also known as the gamma subunit of the Na,K-ATPase, regulates the properties of that enzyme. FXYD1 (phospholemman), FXYD2 (gamma), FXYD3 (MAT-8), FXYD4 (CHIF), and FXYD5 (RIC) have been shown to induce channel activity in experimental expression systems. Transmembrane topology has been established for two family members (FXYD1 and FXYD2), with the N-terminus extracellular and the C-terminus on the cytoplasmic side of the membrane. The protein encoded by this gene is a plasma membrane substrate for several kinases, including protein kinase A, protein kinase C, NIMA kinase, and myotonic dystrophy kinase. It is thought to form an ion channel or regulate ion channel activity. Transcript variants with different 5' UTR sequences have been described in the literature. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

92 residues, UniProt reviewed canonical sequence.

>O00168|FXYD1
     1  MASLGHILVF CVGLLTMAKA ESPKEHDPFT YDYQSLQIGG LVIAGILFIL GILIVLSRRC
    61  RCKFNQQQRT GEPDEEEGTF RSSIRRLSTR RR

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against FXYD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.52
Highest tissue expression
1,675 nTPM

Expression across tissuesHPA

Tissue

  • choroid plexus: 1,675 nTPM
  • skeletal muscle: 1,295 nTPM
  • tongue: 783 nTPM
  • heart muscle: 523 nTPM
  • liver: 521 nTPM
  • basal ganglia: 412 nTPM

Single-cell type

  • bergmann glia: 263 nCPM
  • astrocytes: 116 nCPM
  • choroid plexus epithelial cells: 38 nCPM
  • thymic myoid cells: 34 nCPM
  • schwann cells: 31 nCPM
  • vascular smooth muscle cells: 21 nCPM

Immune cell

  • memory B-cell: 11 nTPM
  • naive B-cell: 6.9 nTPM
  • T-reg: 6.9 nTPM
  • memory CD4 T-cell: 3.6 nTPM
  • NK-cell: 2.1 nTPM
  • basophil: 1.7 nTPM

Brain region

  • choroid plexus: 497 nTPM
  • medulla oblongata: 401 nTPM
  • thalamus: 388 nTPM
  • basal ganglia: 310 nTPM
  • midbrain: 286 nTPM
  • spinal cord: 279 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.85
gnomAD pLI
0.24
gnomAD missense Z
0.53
DepMap mean gene effect
-0.04
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of FXYD1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads FXYD1 as an antibody target. Whether an autoantibody or antibody against FXYD1 could matter depends on whether native FXYD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

FXYD1 is annotated at the cell surface, where native FXYD1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label FXYD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/FXYD1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...